Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,247Revenue $M116Net Margin (%)-45.4Z-Score2.0
Enterprise Value $M1,351EPS $-1.9Operating Margin %-44.5F-Score2
P/E(ttm))0Cash Flow Per Share $0.2Pre-tax Margin (%)-49.6Higher ROA y-yN
Price/Book8.210-y EBITDA Growth Rate %0Quick Ratio4.8Cash flow > EarningsY
Price/Sales10.55-y EBITDA Growth Rate %-38.4Current Ratio5.3Lower Leverage y-yN
Price/Cash Flow73.5y-y EBITDA Growth Rate %0ROA % (ttm)-14.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-36.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.4ROI % (ttm)-21.0Gross Margin Increase y-yN

Gurus Latest Trades with FLDM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

FLDM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


FLDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Yow Mai ChanSee Remarks 2015-04-08Sell30,000$42.673.05 view
JOG VIKRAMCHIEF FINANCIAL OFFICER 2015-04-07Sell3,950$40.817.74 view
JONES ROBERT CEVP, RESEARCH & DEVELOPMENT 2015-04-01Sell3,000$41.635.62 view
Worthington Gajus VincentPRESIDENT & CEO 2015-04-01Sell6,000$40.029.87 view
Smith William MaxwellEVP, LEGAL AFFAIRS & GC 2015-03-16Sell3,000$40.877.59 view
JOG VIKRAMCHIEF FINANCIAL OFFICER 2015-03-09Sell3,950$41.486 view
JONES EVAN/ FADirector 2015-03-02Sell7,500$44.15-0.41 view
JONES ROBERT CEVP, RESEARCH & DEVELOPMENT 2015-03-02Sell3,000$43.780.43 view
Worthington Gajus VincentPRESIDENT & CEO 2015-03-02Sell6,000$43.770.46 view
COLELLA SAMUEL DDirector 2015-02-20Sell44,540$38.9712.83 view

Press Releases about FLDM :

    Quarterly/Annual Reports about FLDM:

    News about FLDM:

    Articles On GuruFocus.com
    No related article found.


    More From Other Websites
    Inogen Gains despite Further Delay in Form 10-K Filing - Analyst Blog Apr 16 2015
    Thoratec Hits 52-Week High on Favorable Developments - Analyst Blog Apr 16 2015
    Masimo to Launch Patient SafetyNet System with Iris, MyView - Analyst Blog Apr 14 2015
    DexCom Launches CGM App on Apple Watch; Shares Rise - Analyst Blog Apr 13 2015
    AngioDynamics Lags Earnings on Lower Sales, View Tepid - Analyst Blog Apr 10 2015
    FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Apr 08 2015
    Luminex (LMNX) Launches NxTAG RPP for Respiratory Testing - Analyst Blog Apr 07 2015
    Inogen Fails 10-K Deadline; Files Form 12b-25 for Extra Time - Analyst Blog Apr 01 2015
    The Best and Worst Medalists of 2015's First Quarter Mar 30 2015
    Inogen's Texas Facility Ready, Costs Likely to Scale Down - Analyst Blog Mar 26 2015
    Abiomed Attains New 52-Week High on Impella 2.5 Approval - Analyst Blog Mar 25 2015
    Abiomed's Impella 2.5 FDA-Approved for PCI Procedures - Analyst Blog Mar 24 2015
    Cantel Medical Beats Q2 Earnings, Provides Positive Outlook - Analyst Blog Mar 13 2015
    Inogen (INGN) Postpones Q4 Results; Reiterates 2015 View - Analyst Blog Mar 12 2015
    FLUIDIGM CORP Financials Mar 05 2015
    Symmetry Surgical Posts Loss in Q4, Revenues Decline Y/Y - Analyst Blog Mar 02 2015
    10-K for Fluidigm Corp. Feb 28 2015
    FLUIDIGM CORP Files SEC form 10-K, Annual Report Feb 26 2015
    SNP Trace Panel Proves to Be a High-Throughput, Cost-Effective SNP-Based Platform for Profiling... Feb 25 2015
    Fluidigm to Present at the 35th Annual Cowen & Company Health Care Conference Feb 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK